Literature DB >> 7032554

Calcium antagonist drugs in chronic stable angina. Comparison of verapamil and nifedipine.

J R Dawson, N H Whitaker, G C Sutton.   

Abstract

The relative efficacy of two calcium antagonist drugs, verapamil, 120 mg three times a day and nifedipine, 20 mg three times a day, was examined in a double-blind randomised trial. Patients were assessed at the end of four week periods by a maximal treadmill exercise test, the frequency of anginal attacks, glyceryl trinitrate consumption, and side effects. Sixteen point praecordial maps were recorded at rest, immediately after exercise, and at minute intervals for 10 minutes. Total ST segment depression (epsilon ST) was used as a measure of myocardial ischaemia. Both verapamil and nifedipine increased maximal work capacity but epsilon ST at the termination of the test remained constant. Both drugs reduced the frequency of anginal attacks and glyceryl trinitrate consumption. Systolic blood pressure at rest and on exercise was reduced by both drugs. Verapamil and nifedipine were equally effective in treating angina, but side effects were more common with nifedipine.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7032554      PMCID: PMC482688          DOI: 10.1136/hrt.46.5.508

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  14 in total

1.  The electrocardiographic diagnosis of acute myocardial ischemia.

Authors:  G B MYERS; F N TALMERS
Journal:  Ann Intern Med       Date:  1955-08       Impact factor: 25.391

2.  Verapamil in ischaemic heart disease--quantitative assessment by serial multistage treadmill exercise.

Authors:  V Balasubramanian; P K Khanna; G R Naryanan; R S Hoon
Journal:  Postgrad Med J       Date:  1976-03       Impact factor: 2.401

Review 3.  Control of myocardial oxygen consumption: physiologic and clinical considerations.

Authors:  E Braunwald
Journal:  Am J Cardiol       Date:  1971-04       Impact factor: 2.778

4.  Effects of nifedipine after intravenous and intracoronary administration.

Authors:  M Kaltenbach; W Schulz; G Kober
Journal:  Am J Cardiol       Date:  1979-10-22       Impact factor: 2.778

5.  Haemodynamic effects of intravenous verapamil at rest and during exercise in subjectively healthy middle-aged men.

Authors:  J H Atterhög; L G Ekelund
Journal:  Eur J Clin Pharmacol       Date:  1975-06-13       Impact factor: 2.953

6.  Effect of nifedipine on atrioventricular conduction as compared with verapamil. Intracardiac electrophysiological study.

Authors:  E Rowland; T Evans; D Krikler
Journal:  Br Heart J       Date:  1979-08

7.  A method for praecordial surface mapping of the exercise electrocardiogram.

Authors:  K M Fox; A P Selwyn; J P Shillingford
Journal:  Br Heart J       Date:  1978-12

8.  Effect of verapamil on coronary hemodynamics in patients with coronary heart disease.

Authors:  S Simonsen
Journal:  Eur J Cardiol       Date:  1978-08

9.  Comparative effects of nifedipine, verapamil, isosorbide dinitrate and propranolol on exercise-induced angina pectoris.

Authors:  C de Ponti; F Mauri; G R Ciliberto; B Carù
Journal:  Eur J Cardiol       Date:  1979-07

10.  Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination.

Authors:  P Lynch; H Dargie; S Krikler; D Krikler
Journal:  Br Med J       Date:  1980-07-19
View more
  11 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

2.  Immediate and long-term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease.

Authors:  C A Visser; W Jaarsma; G Kan; J J Koolen; K I Lie
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

3.  Projection of ST segment changes on to the front of the chest. Practical implications for exercise testing and ambulatory monitoring.

Authors:  K M Fox; J Deanfield; P Ribero; D England; C Wright
Journal:  Br Heart J       Date:  1982-12

4.  Comparison of dihydropyridine and phenylalkylamine calcium antagonists in patients with coronary heart disease.

Authors:  G F Rettig; M Jakob; S Sen; A Heisel
Journal:  Drugs       Date:  1991       Impact factor: 9.546

5.  Effect of coadministration of verapamil and quinidine on serum digoxin concentration.

Authors:  W Doering
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  The effects on left ventricular performance of nifedipine and verapamil in exercise-induced angina pectoris.

Authors:  B Silke; S P Verma; G I Nelson; R C Ahuja; M Hussain; S H Taylor
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

Review 7.  Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

Review 8.  Calcium channel antagonists. Part IV: Side effects and contraindications drug interactions and combinations.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-07       Impact factor: 3.727

9.  Improvement in angina pectoris with alpha adrenoceptor blockade.

Authors:  P Collins; D Sheridan
Journal:  Br Heart J       Date:  1985-05

10.  Pharmacokinetic, haemodynamic and radionuclide studies with nicardipine in coronary artery disease.

Authors:  B Silke; D J Graham; S P Verma; G Reynolds; M A Frais; J R Finlayson; S H Taylor
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.